Literature DB >> 33214456

Response to the Comment on "Acute Kidney Injury After Esophageal Cancer Surgery: Incidence, Risk Factors, and Impact on Oncologic Outcomes".

Conor F Murphy, Talulla Dunne, Jessie A Elliott, Sivesh K Kamarajah1, James Leighton1, Richard P T Evans2, James Bundred2, Sinead King3, Narayanasamy Ravi3, Claire L Donohoe3, S Michael Griffin4, Ewen A Griffiths2, Alexander W Phillips4, John V Reynolds3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33214456     DOI： 10.1097/SLA.0000000000004609

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  4 in total

1.  ASO Author Reflections: Endoscopic Resection or Gastrectomy for Early Clinical Stage T1a or T1b Gastric Adenocarcinoma.

Authors:  Sivesh K Kamarajah; Sheraz R Markar; Alexander W Phillips
Journal:  Ann Surg Oncol       Date:  2021-01-21       Impact factor: 5.344

2.  Is Prophylactic Cervical Drainage Effective in Patients Undergoing McKeown Esophagectomy Reconstructed Through the Retrosternal Route with Two-Field Lymphadenectomy?

Authors:  Daisuke Fujiwara; Masayuki Watanabe; Yasukazu Kanie; Suguru Maruyama; Kei Sakamoto; Akihiko Okamura; Jun Kanamori; Yu Imamura; Shinji Mine
Journal:  World J Surg       Date:  2022-04-20       Impact factor: 3.282

Review 3.  [Impact of COVID-19 on oncological surgery of the upper gastrointestinal tract].

Authors:  Benjamin Babic; Rabi R Datta; Wolfgang Schröder; Lars M Schiffmann; Thomas Schmidt; Christiane J Bruns; Hans F Fuchs
Journal:  Chirurg       Date:  2021-08-27       Impact factor: 0.955

4.  Completely minimally invasive versus hybrid Ivor-Lewis oesophagectomy for oesophageal and gastro-oesophageal junctional cancer: a UK multi-centre comparative study.

Authors:  Krashna Patel; Alan Askari; Omar Abbassi; Naga Venkatesh Jayanthi; Oliver Claydon; James Laycock; Aravindh Ramalingam; Bhaskar Kumar; Joshua Wong; Mohamed Aly; Periyathambi Jambulingam
Journal:  Surg Endosc       Date:  2022-01-19       Impact factor: 3.453
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.